Agranulocytosis and Hepatitis as a Result of Mexican Drug Therapy
Authors:
- 1 January 1984
- journal article
- case report
- Published by SAGE Publications in Drug Intelligence & Clinical Pharmacy
- Vol. 18 (1) , 66-68
Abstract
A 26-year-old woman with debilitating juvenile rheumatoid arthritis was treated at a Mexican arthritis clinic with two unknown medications. She subsequently developed agranulocytosis and cholestatic hepatitis as an adverse reaction to these drugs, later identified as oxyphenbutazone and diazepam. The etiology of these drug-induced problems is reviewed, and the dangers of this unorthodox form of medical therapy are discussed.Keywords
This publication has 10 references indexed in Scilit:
- Diazepam (Valium) hepatitisDigestive Diseases and Sciences, 1982
- Phenylbutazone liver injury: A clinical-pathologic survey of 23 cases and review of the literatureHepatology, 1981
- Drug-induced AgranulocytosisClinics in Haematology, 1980
- Mexican drug therapyClinical Toxicology, 1980
- Drug-Induced Liver DiseaseDrugs, 1978
- Drug-Induced AgranulocytosisDrugs, 1978
- Granulomas and cholestatic-hepatocellular injury associated with phenylbutazoneDigestive Diseases and Sciences, 1977
- Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone.BMJ, 1977
- Hepatic Necrosis and Other Visceral Lesions Associated with Phenylbutazone TherapyBMJ, 1955
- HEPATITIS FOLLOWING THE INGESTION OF PHENYLBUTAZONEJAMA, 1954